Stay updated with breaking news from Wyliew Vale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced it received Breakthrough Therapy designation from the U.S. Food and Drug...
Subjecting mice to repeated emotional stress, the kind we experience in everyday life, may contribute to the accumulation of neurofibrillary tangles, one of the hallmarks of Alzheimer’s disease, report researchers at the Salk Institute for Biological Studies.
Artia Global Partners LP purchased a new stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 45,000 shares of the company’s stock, valued at approximately $5,375,000. Neurocrine Biosciences accounts for approximately […]
Neurocrine Biosciences (NASDAQ:NBIX – Get Rating) had its target price lowered by Stifel Nicolaus from $145.00 to $125.00 in a report published on Tuesday, The Fly reports. Several other equities research analysts have also commented on the stock. Royal Bank of Canada raised their price target on shares of Neurocrine Biosciences from $106.00 to $108.00 […]
Neurocrine Biosciences (NASDAQ:NBIX – Get Rating) had its target price boosted by Royal Bank of Canada from $106.00 to $108.00 in a report issued on Monday, The Fly reports. A number of other equities analysts have also commented on the stock. Citigroup decreased their price objective on shares of Neurocrine Biosciences from $127.00 to $122.00 […]